共 50 条
Porcine embryonic stem cells: An alternative solution for the shortage of human islets to treat type 1 diabetes?
被引:0
作者:
Nottle, Mark B.
[1
,2
]
Vassiliev, Ivan
[1
,2
]
Hawthorne, Wayne J.
[3
,4
]
Cowan, Peter J.
[5
,6
]
机构:
[1] Univ Adelaide, Robinson Res Inst, Adelaide, SA 5005, Australia
[2] Univ Adelaide, Sch Biomed, Adelaide, SA 5005, Australia
[3] Westmead Inst Med Res, Ctr Transplant & Renal Res, Westmead, NSW, Australia
[4] Univ Sydney, Westmead Hosp, Sch Med Sci, Dept Surg, Westmead, NSW, Australia
[5] St Vincents Hosp, Immunol Res Ctr, Melbourne, Vic, Australia
[6] Univ Melbourne, Dept Med, Melbourne, Vic, Australia
关键词:
islet transplantation;
porcine embryonic stem cells;
type;
1;
diabetes;
IN-VITRO;
D O I:
10.1111/xen.12840
中图分类号:
R-3 [医学研究方法];
R3 [基础医学];
学科分类号:
1001 ;
摘要:
Transplantation of human embryonic stem cell (ESC) derived beta-like cells and xenotransplantation of porcine islets are two potential cures for type 1 diabetes (T1D). We have previously reported the isolation of porcine ESCs and have also separately shown that islets from genetically modified pigs can effectively cure diabetes in a preclinical baboon model. Here we discuss the possibility of combining these technologies to produce gene-edited porcine ESC-derived islets as an alternative for treating T1D, which may offer several advantages compared with these approaches.
引用
收藏
页数:3
相关论文
共 50 条